Drugs / Danzhen
last change Jul 2017 re-read 9 days ago

Danzhen

Developed for
migraine disorder
Investigated by
Ecion Pharmaceutical CO..LTD · Xijing Hospital

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02645370 Feb 2016 → Jul 2017 migraine disorder Xijing Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Danzhen ClinicalTrials.gov intervention name — accepted as the source's own label NCT02645370 ↗